http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (3): 284-292.DOI: 10.5246/jcps.2025.03.022

• Drug administration and clinical pharmacy column • Previous Articles    

Meta-analysis of the clinical efficacy of wax therapy combined with conventional pharmacotherapy in rheumatoid arthritis treatment

Wangxing Zeng1,#, Qian Deng1,#, Zining Peng1,#, Fanyu Meng1, Weitian Yan2,*(), Nian Liu1,*(), Jiangyun Peng2,*()   

  1. 1 First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, Yunnan, China
    2 Department of Rheumatology, The No.1 Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, Yunnan, China
  • Received:2024-07-13 Revised:2024-09-26 Accepted:2024-11-24 Online:2025-03-31 Published:2025-04-01
  • Contact: Weitian Yan, Nian Liu, Jiangyun Peng
  • About author:

    # Wangxing Zeng, Qian Deng and Zining Peng contributed equally to this work.

  • Supported by:
    The Key Research and Development Program of Yunnan Science and Technology Department (Grant No. 202303AC100326), the National Natural Science Foundation of China (Grant No. 81960863) and the Education Department of Yunnan Province (Grant No. 2023Y0463 and 2024Y380).

Abstract:

This study aimed to systematically evaluate the clinical efficacy of combining wax therapy with conventional drug therapy for rheumatoid arthritis (RA) and to provide evidence supporting its clinical application. A comprehensive search was conducted across PubMed, Cochrane Library, China Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases from their inception to May 2024. Randomized controlled trials (RCTs) investigating the combination of wax therapy and conventional drug therapy for RA were included in the analysis. Statistical analysis was performed using Review Manager 5.3 software. Nine studies, encompassing a total of 843 patients, were included. The results demonstrated that the combination therapy significantly improved clinical efficacy compared to conventional drug therapy alone [RR = 1.22, 95% CI (1.11, 1.34)]. Moreover, the combination therapy led to notable improvements in DAS 28 scores [MD = –0.90, 95% CI (–1.23, –0.57), P < 0.00001], VAS scores [MD = –0.90, 95% CI (–1.13, –0.66), P < 0.00001], reduction in joint tenderness [MD = –1.27, 95% CI (–1.81, –0.72), P < 0.00001], decreased duration of morning stiffness [MD = –25.47, 95% CI (–34.33, –16.61), P < 0.00001], and lowered C-reactive protein levels [MD = –6.29, 95% CI (–12.02, –0.57), P < 0.05]. In conclusion, wax therapy combined with conventional anti-rheumatic drugs significantly enhanced the clinical outcomes for RA patients by alleviating symptoms, reducing joint pain and morning stiffness, and decreasing inflammatory markers more effectively than conventional drug therapy alone.

Key words: Rheumatoid arthritis, Wax therapy, Clinical effects, Meta-analysis

Supporting: